Literature DB >> 7508808

Evidence that corticotropin-releasing factor within the extended amygdala mediates the activation of tryptophan hydroxylase produced by sound stress in the rat.

M C Boadle-Biber1, V B Singh, K C Corley, T H Phan, R P Dilts.   

Abstract

Non-endocrine corticotropin-releasing factor (CRF) is believed to be involved in mediating stress behaviors in rats. The present study investigated the role of CRF in mediating the activation of tryptophan hydroxylase, the rate-limiting enzyme in serotonin synthesis, produced in response to sound stress. Bilateral injections of 0.5-3.0 micrograms of CRF directed towards the central nucleus of the amygdala increased tryptophan hydroxylase activity measured ex vivo when compared to vehicle-injected controls. This increase in enzyme activity, like that due to sound stress, was reversed in vitro by alkaline phosphatase. Intra-amygdala CRF (0.5 microgram) also enhanced the in vivo accumulation of 5-hydroxytryptophan (5-HTP) following the administration of m-hydroxylbenzylamine (NSD-1015, 200 mg/kg). The activation of tryptophan hydroxylase, produced by intra-amygdala CRF, was blocked by the CRF receptor antagonist alpha-helical CRF9-41 (10 micrograms). Additionally, the 5-HT1A agonist, gepirone, given either systemically (10 mg/kg) or intracerebrally into the region of the dorsal raphe (14 micrograms), blocked the tryptophan hydroxylase response to CRF. CRF did not increase tissue levels of 5-hydroxyindole acetic acid (5-HIAA) or the ratio of 5-HIAA to serotonin (5-HT) within the striatum of the same animals in which tryptophan hydroxylase activity was quantified, an effect produced by sound stress. Thus, while intra-amygdala CRF failed to mimic the sound stress response in its entirety, these data suggest that CRF is involved in mediating the activation of tryptophan hydroxylase produced by sound stress within the midbrain serotonin neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508808     DOI: 10.1016/0006-8993(93)90944-i

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Investigation of a central nucleus of the amygdala/dorsal raphe nucleus serotonergic circuit implicated in fear-potentiated startle.

Authors:  B M Spannuth; M W Hale; A K Evans; J L Lukkes; S Campeau; C A Lowry
Journal:  Neuroscience       Date:  2011-01-26       Impact factor: 3.590

Review 2.  [The significance of stress: its role in the auditory system and the pathogenesis of tinnitus].

Authors:  B Mazurek; T Stöver; H Haupt; B F Klapp; M Adli; J Gross; A J Szczepek
Journal:  HNO       Date:  2010-02       Impact factor: 1.284

3.  Distress calls of the greater short-nosed fruit bat Cynopterus sphinx activate hypothalamic-pituitary-adrenal (HPA) axis in conspecifics.

Authors:  Subramanian Mariappan; Wieslaw Bogdanowicz; Ganapathy Marimuthu; Koilmani Emmanuvel Rajan
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2013-07-06       Impact factor: 1.836

4.  Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone.

Authors:  G E Stutzmann; B S McEwen; J E LeDoux
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

5.  Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe.

Authors:  M S Clark; R A McDevitt; B J Hoplight; J F Neumaier
Journal:  Neuroscience       Date:  2007-04-30       Impact factor: 3.590

Review 6.  Childhood trauma and personality disorder: toward a biological model.

Authors:  Royce Lee
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

7.  AGN-2979, an inhibitor of tryptophan hydroxylase activation, does not affect serotonin synthesis in Flinders Sensitive Line rats, a rat model of depression, but produces a significant effect in Flinders Resistant Line rats.

Authors:  Kazuya Kanemaru; Kyoko Nishi; Mirko Diksic
Journal:  Neurochem Int       Date:  2009-05-20       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.